The Food and DrugAdministration has approved Symbicort for residents suffering from ChronicObstructive Pulmonary Disease COPD). The medication is intended for twice dailyuse. In two clinical trials, ...
The U.S. Food and Drug Administration on Tuesday approved the first generic Symbicort drug used to treat asthma and chronic obstructive pulmonary disease (COPD), which are two common pulmonary health ...
WASHINGTON, Feb 27 (Reuters) - U.S. health regulators have approved AstraZeneca Plc's asthma drug Symbicort to also treat patients with the lung disorder known as COPD, or chronic obstructive ...
Pittsburgh-based Highmark Health signed an outcomes-based contract with drugmaker AstraZeneca for its asthma and chronic obstructive pulmonary disease drug Symbicort. The contract will apply to ...
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called ...
Drugmaker AstraZeneca said it intends to cap out-of-pocket prices of four medicines used to treat asthma and chronic obstructive pulmonary disease (COPD) to $35 per month for many patients. Starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results